Samaritan Bio
PrivateLast Round
Corporate Funding
Nov 13, 2024
Total Funding Raised
$8M
Company Overview
Samaritan Bio is a medical technology company that develops AI-driven urine analysis systems for the predictive monitoring of acute kidney injury and chronic kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, EHR & EMR, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Samaritan Bio Comparables
Compare Samaritan Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exypnos Medical | 85% | |
| RenalSense Ltd. | 83% | |
| Serenno Medical | 83% |
Samaritan Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Nov 13, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2024
Raised $8M in corporate funding.
Samaritan Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Samaritan Bio's valuation, stock price, and market status.
Is Samaritan Bio a public or private company?
Samaritan Bio is a private company.
What is the current stock price of Samaritan Bio?
Samaritan Bio is a private company, so its shares have no public market price. Caplight tracks Samaritan Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Samaritan Bio worth (valuation)?
Valuation information for Samaritan Bio is not publicly available.
Can I buy Samaritan Bio stock?
Samaritan Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Samaritan Bio's last funding round?
Samaritan Bio's most recent funding round was Corporate Funding on November 13, 2024.
Who are the main investors in Samaritan Bio?
Investor information for Samaritan Bio is not publicly disclosed.
Will Samaritan Bio IPO soon?
No public IPO plans have been announced for Samaritan Bio.
How can I track Samaritan Bio secondary market activity?
Caplight tracks bids, offers, and trades in Samaritan Bio's shares on secondary markets.